Study to Assess the Efficacy and Safety of Treatment of Articular Cartilage Lesions With CartiLife®

Articular Cartilage Lesion of the Knee Clinical Trial

Official title: A Multi-Center, Active-Controlled, Open-Label, Phase Ⅱ Trial to Compare the Efficacy and Safety for Treatment of Autologous Chondrocytes Implantation With CartiLife Versus Microfracture for Patient With Chondral Defects in the Knee

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of implanting bead-type autologous chondrocyte (CartiLife®) obtained by culturing expanded costal chondrocytes of the patient with a chondral defect in the knee. The patients will be assessed clinically using MRI, clinical, biochemical and International Knee Documentation Committee(IKDC) outcomes preoperatively as well as 8, 24 and 48 weeks postoperatively to assess the relief of symptoms and joint function.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Articular Cartilage Lesion of the Knee

• NCT number: NCT03545269
• Study type: Interventional
• Source: Biosolution Co., Ltd.
• Status: Completed
• Phase: Phase 2
• Start date: February 3, 2014
• Completion date: February 23, 2017